Jan Hörling

Jan Hörling has a diverse and extensive work experience in the healthcare and biotechnology industries. Jan served as the Vice President of Global Marketing and Vice President of Research & Development at Wellspect HealthCare from 2014 to the present. Prior to that, they were a Member of the Board at OncoTargeting AB from 2008 to 2014. Jan also held multiple roles at GE Healthcare, including Research Director, Head of R&D Protein Analysis, Head of Strategic Technologies, and Head of R&D Biacore, from 2008 to 2013. Jan was Chairman of the Board and Co-founder of Meira Life Science AB from 2008 to 2010. Jan's earlier experience includes Vice President and Director roles at Discovery Research, Biovitrum, where they led various departments and projects related to discovery and biological aspects. Jan began their career as a Team Leader at Pharmacia.

Jan Hörling's education history is as follows:

From 2015 to 2018, Jan Hörling attended Uppsala University, where they studied CSR & Sustainability, Marketing, and Lean Product Development. They did not obtain a specific degree during this time.

From 2006 to 2009, Jan Hörling pursued an eMBA degree at Swedish Management Group. Their focus was on Finance, Strategy, and Leadership.

Between 1989 and 1996, Jan Hörling studied at Karolinska Institutet, completing a Dr. Med. Sci. degree in Molecular and Immunological Virology.

Starting in 1986 and ending in 1990, Jan Hörling attended Stockholm University, where they obtained an M.Sc. degree in Biology.

In addition, Jan Hörling has obtained several certifications. Most recently, they received a certification in Board Work from Västsvenska Handelskammaren in November 2022. They have also earned certifications from LinkedIn in various topics such as leadership, decision-making, presentations, credibility-building, and strategic thinking. The LinkedIn certifications were obtained between 2021 and 2022.